What we do

The BC Centre for Disease Control (BCCDC)

Presently, researchers at BCCDC are principal investigators and co-investigators on 42 research grants and contracts worth a total of 27 million dollars. Research funding for the 2007/8 fiscal year is approximately 3.7 million dollars. For a comprehensive list of BCCDC projects visit: http://www.cdc.ubc.ca/Research/Research.htm.

CDC logo

R&D Highlights

Researcher Project Title Funding Agency Term
Brunham, Robert Development of a Chlamydia T Cell Vaccine Based on Dendritic Cell Immunoprotemics National Institutes of Health  
Brunham, Robert CRA: Accelerated Chlamydia trachomatis Immunoproteomic Vaccine Enterprise (ACTIVE) Genome British Columbia 2006-2008
Brunham, Robert Developing a Chlamydia trachomatis vaccine by optimizing dendritic cell responses CIHR/Rx&D Research Program 2005-2007
Brunham, Robert Development of a Rapid Screen to Determine the Effect of Adjuvants and Chlamydia trachomatis Proteins on Murine Dendritic Cells: Implications for Vaccine Development Aventis-Pasteur 2005-2007
Brunham, Robert Biological and Immunologenic Evaluation of C. trachomatis Vaccine Candidate Antigens and Formulations Sanofi-Pasteur 2005-2007
Brunham, Robert Immunobiology of Chlamydia trachomatis infection CIHR: Operating Grant 2001-2006
Brunham, Robert Comparative genomics of the Chlamydiaceae family of obligate intracellular parasites: a study of new laboratory methods to better understand Chlamydia infection NIH (US): Research Grant 2003-2006
Brunham, Robert SAVI: SARS Accelerated Vaccine Initiative BC Ministry of Health 2003-2005
Brunham, Robert A scientific collaborative to support public health response to SARS CIHR 2003-2004


Did you know?
image of influenza virus

The three influenza viruses that affect humans are Influenzavirus A (humans, other mammals & birds), Influenzavirus B (humans & seals), and Influenzavirus C (humans & pigs). Influenzavirus A is responsible for most flu pandemics. The virus can be transmitted through airborne particles – coughs or sneezes – contaminated surfaces, or in the case of avian influenza, through infected bird droppings. The influenza virus can survive in sub-zero temperatures, but is easily killed with disinfectants and detergents.

BACKGROUNDER

Immunization:
Inoculation and Vaccination

Inoculation (also known as variolation) was introduced to the west by Lady Mary Wortley Montagu (1689-1762), who witnessed inoculation being
portrait of lady
practiced by physicians in Constantinople,[12] and was greatly impressed:[13] she had lost a brother to smallpox and bore facial scars from the disease herself. In 1718 she had the embassy surgeon inoculate her son, and in 1721, after returning to England, had her daughter inoculated[14]. In 1722 the Prince of Wales' daughters received inoculations[16].

The practice of inoculation slowly spread amongst the royal families of Europe, followed by general adoption amongst the rest of the population. Given the severe consequences of smallpox in Europe in the 18th century, many parents felt that the benefits outweighed the risks and so inoculated their children.[21] [22]